Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus

DENDRITIC cells are a complex group of mainly bone-marrow-derived leukocytes that play a role in autoimmune diseases. The total number of circulating dendritic cells (tDC), and their plasmacytoid dendritic cell (pDC) and myeloid dendritic cell (mDC1 and mDC2) subpopulations were assessed using flow...

Full description

Bibliographic Details
Main Authors:	E. Robak, P. Smolewski, A. Wozniacka, A. Sysa-Jedrzejowska, T. Robak
Format:	Article
Language:	English
Published:	Hindawi Limited 2004-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1080/09511920410001713538

Similar Items

Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
by: Ewa Robak, et al.
Published: (1999-01-01)

Lymphocytes Tγδ in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity
by: Ewa Robak, et al.
Published: (2001-01-01)

Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients
by: Anna Wozniacka, et al.
Published: (2003-01-01)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus
by: Ewa Robak, et al.
Published: (2003-01-01)

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes
by: E. Robak, et al.
Published: (1996-01-01)

The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects.
by: Anna Zalewska, et al.
Published: (2006-04-01)

Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
by: Agnieszka Klonowska-Szymczyk, et al.
Published: (2014-01-01)

Cognitive functions and autoantibodies in patients with systemic lupus erythematosus
by: Anna Bogaczewicz, et al.
Published: (2016-06-01)

The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosus
by: Kamila Tokarska, et al.
Published: (2019-11-01)

Hemophagocytic syndrome in systemic lupus erythematosus
by: Agata Liszewska, et al.
Published: (2019-08-01)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
by: Ewa Robak, et al.
Published: (2006-01-01)

Current views on etiopathogenesis of systemic lupus erythematosus
by: Agnieszka Klonowska-Szymczyk, et al.
Published: (2011-11-01)

The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus
by: Agnieszka Klonowska-Szymczyk, et al.
Published: (2017-10-01)

Variability of the rs333 in Polish patients with lupus erythematosus
by: Dominika Mlicka, et al.
Published: (2021-03-01)

The evaluation and optimal use of rituximab in lymphoid malignancies
by: Smolewski P, et al.
Published: (2012-01-01)

The examination of the relationship between cognitive functions and cardiovascular condition in systemic lupus erythematosus patients without obvious neuropsychiatric features
by: Anna Bogaczewicz, et al.
Published: (2015-12-01)

Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
by: Xiaolan Zheng, et al.
Published: (2019-01-01)

Role of Toll-like receptors in etiology of selected diseases of the skin
by: Lilianna Kulczycka, et al.
Published: (2010-08-01)

Clinical significance of laboratory errors in patients with systemic lupus erythematosus
by: N.G. Klyukvina
Published: (2014-05-01)

Clinical significance of antinucleosome antibodies in patients with “early” systemic lupus erythematosus
by: M. A. Kotovskaya, et al.
Published: (2016-05-01)

Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus
by: Patcharee Ritprajak, et al.
Published: (2019-10-01)

Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus
by: Jinlin Miao, et al.
Published: (2016-01-01)

The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.
by: Ilan Ben-Zvi, et al.
Published: (2010-02-01)

Clinical significance of serum and urinary interleukin-6 in systemic lupus erythematosus patients
by: A. Dima, et al.
Published: (2017-01-01)

Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells
by: Xiaofeng Liao, et al.
Published: (2016-01-01)

Treatment of Systemic Lupus Erythematosus by Nutrition and Dendritic Cell Targeting
by: Liao, Xiaofeng
Published: (2017)

Clinical significance of red blood cell distribution width in systemic lupus erythematosus patients
by: Osama Sayed Daifallah Mohamed, et al.
Published: (2020-09-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01)

Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus
by: Jaroslaw Bogaczewicz, et al.
Published: (2019-01-01)

Estimation of SLE Activity Based on the Serum Level of Chosen Cytokines and Superoxide Radical Generation
by: Elzbieta Waszczykowska, et al.
Published: (1999-01-01)

The Role of Plasmacytoid Dendritic Cells and Natural Killer Cells in Systemic Lupus Erythematosus
by: Hagberg, Niklas
Published: (2014)

Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus.
by: Patricia L Lugar, et al.
Published: (2012-01-01)

Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus.
by: Xuebing Feng, et al.
Published: (2012-01-01)

THE SIGNIFICANCE OF C‑REACTIVE PROTEIN IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: S. M. Noskov, et al.
Published: (2014-07-01)

THE SIGNIFICANCE OF C‑REACTIVE PROTEIN IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: S. M. Noskov, et al.
Published: (2014-07-01)

Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools
by: Jared Klarquist, et al.
Published: (2016-01-01)

Significance of damage index in prediction of systemic lupus erythematosus outcome
by: I A Tarasova, et al.
Published: (2003-01-01)

Clinical Profile of Patients with Systemic Lupus Erythematosus
by: B Paudyal, et al.
Published: (2012-09-01)

Clinical significance of lipid profile in systemic lupus erythematosus patients: Relation to disease activity and therapeutic
by: Mayada Ali Abdalla, et al.
Published: (2017-04-01)

Clinical significance of vitamin D deficiency and receptor gene polymorphism in systemic lupus erythematosus patients
by: Kamel H. Gado, et al.
Published: (2017-07-01)